Gilead Sciences Inc. Earnings

Gilead Sciences Inc.’s revenue jumped 4.7% since last year same period to $7925Mn in the Q4 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated 2.01% jump in its revenue since last 3-months.

Gilead Sciences Inc.’s net profit jumped 22.43% since last year same period to $2183Mn in the Q4 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated -28.47% fall in its net profits since last 3-months.

Gilead Sciences Inc.’s net profit margin jumped 16.93% since last year same period to 27.55% in the Q4 2025. On a quarterly growth basis, Gilead Sciences Inc. has generated -29.88% fall in its net profit margins since last 3-months.

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.89 - a 2.16% jump from last quarter’s estimates.

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.89.

Gilead Sciences Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Gilead Sciences Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Gilead Sciences Inc. declared 0.82 dividend per share during the earnings announcement for Q1 2026.